Pharmaceutical imports are the most tightly controlled cargo most Pakistani importers will ever handle, and the controls sit almost entirely before the goods arrive. By the time a consignment of medicines lands at Karachi, the decisions that determine whether it clears in days or sits for weeks were made when the order was placed. This article covers how pharmaceutical clearance actually works and where it goes wrong.
Two authorities, not one
A pharmaceutical consignment answers to Pakistan Customs for duty, classification and valuation, and to the Drug Regulatory Authority of Pakistan for whether the product may lawfully be imported at all. These run in parallel, and the second is usually the binding constraint.
Customs will not release a regulated pharmaceutical product without the regulatory position being satisfied, so an importer with perfect customs documentation and an incomplete regulatory file has a consignment going nowhere. Understanding which authority is actually holding your cargo is the first diagnostic step when something stalls.
The regulatory gate
DRAP regulates therapeutic goods in Pakistan — medicines, biologicals, medical devices and related products. Importing commercially requires the importer to hold the appropriate authorisation, and the product itself to have a recognised regulatory status. The two are separate: being licensed to import does not entitle you to import anything you like.
Import approvals have moved online in recent years, with DRAP operating an electronic service portal and import no-objection processing being handled through the Pakistan Single Window. Because these arrangements have changed more than once, confirm the current route and requirements before each consignment rather than relying on how it worked last year.
Medical devices are a separate regime
Devices are regulated under the Medical Devices Rules, and the framework is risk-based: devices are classified by risk class, and what is required of an importer varies with that classification. Establishment licensing applies to those importing and distributing devices, distinct from the product-level requirements.
A frequent and expensive assumption is that a product which is not a medicine is therefore unregulated. Surgical instruments, diagnostic equipment, laboratory analysers and consumables can all fall within the device framework. Establish the classification before ordering, because it determines the entire import pathway.
Release on arrival
For many pharmaceutical consignments, regulatory involvement does not end with a pre-shipment approval. Release procedures apply on arrival, with the consignment examined against its documentation before it is cleared to enter the supply chain.
This is where cold chain and clearance intersect. A temperature-sensitive product waiting on a release is a product dependent on transport equipment rather than validated storage, which is why pharmaceutical consignments need their documentary and regulatory file complete before the aircraft lands, not after.
Documentation
- Regulatory authorisation appropriate to the product and the importer
- Commercial invoice and packing list with full product identification, not brand names alone
- Batch and lot details, manufacturing and expiry dates
- Certificate of analysis for the specific batch
- Manufacturer and free sale certification where required
- Transport document, with temperature records for cold chain consignments
- Shelf-life position on arrival, since remaining life requirements can apply
The batch-level documentation is what separates pharmaceutical files from ordinary ones. A certificate of analysis issued for a different lot than the one that arrived is a real and recurring cause of delay, and it is entirely avoidable with a check before dispatch.
Classification and duty
Pharmaceutical tariff treatment varies considerably across formulations, active ingredients, devices and consumables, and the correct classification is what determines both the duty position and whether any concession applies. Getting it wrong in either direction is costly: overpayment is silent, underpayment surfaces later as a recovery case.
Because the products are often high value per kilogram, classification errors compound quickly. It is worth resolving before the first consignment of a new product rather than after several have been cleared on an assumption.
Where consignments actually get stuck
- Regulatory approval applied for after shipment, or issued against different product details
- Certificate of analysis covering a different batch than the one shipped
- Insufficient remaining shelf life on arrival
- Product description too generic to establish regulatory status or classification
- A device assumed to be unregulated, discovered to be within the device rules
- Cold chain documentation missing, so conditions in transit cannot be evidenced
Air freight and timing
Most pharmaceutical imports move by air, and for good reason: shorter exposure, tighter temperature control and less time in an uncontrolled environment. That does not remove the need for preparation — it concentrates it, because an air consignment can land two days after dispatch and find its approval still pending.
Building a repeatable process
Importers who handle pharmaceuticals well treat each consignment as an instance of a defined process rather than as a fresh problem. The elements are unglamorous but they compound: a product register recording the regulatory status and classification of every item imported, so nothing is ordered without its position being known; a document template listing what each product requires, so nothing is discovered missing at the airport; and a calendar of licence and registration renewals, so nothing lapses quietly.
The renewal point is worth emphasising because it causes disproportionate damage. Authorisations have validity periods, and a lapse discovered when a consignment is already in the air converts a routine import into an emergency. Renewals should be diarised well in advance of expiry rather than triggered by a problem.
The same discipline applies to your supplier. Manufacturing sites, product presentations and pack configurations change, and a change at origin can invalidate the documentary position at destination. Asking the supplier to notify you of changes to the registered particulars is a small request that prevents a category of failure entirely.
ASC Freight handles pharmaceutical clearance through its pharmaceutical desk and the associated DRAP and ADC processing, coordinated with air freight so the regulatory and transport legs are planned together rather than sequentially.
- pharmaceutical imports
- DRAP
- medicines
- medical devices
- regulated cargo
